# A Pharmacokinetic Study of Avanfil in Healthy Young Male Subjects

> **NCT00914511** · PHASE1 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 32 (actual)

## Conditions studied

- Avanfil ADME
- Semen Exposure
- Sperm Function

## Interventions

- **DRUG:** avanafil 200mg
- **DRUG:** avanafil 200mg

## Key facts

- **NCT ID:** NCT00914511
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2011-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914511, "A Pharmacokinetic Study of Avanfil in Healthy Young Male Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00914511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*